Moreover, in 2008, there was a successful treatment using IL-2 therapy for persistent cryptococcal meningitis in a child with idiopathic CD4+ T lymphocytopenia68, suggesting that IL-2 immunotherapy could be safe for HIV/AIDS patients. This evidence concerns the gene IL2 and Cryptococcal meningitis.